The FDA’s ‘data guy’ should trust the data on the abortion pill
Summary by The Hill
3 Articles
3 Articles
All
Left
Center
2
Right
1
FDA Must Make it Clear Abortion Pills are Dangerous for Women
FDA Commissioner Marty Makary has recently promised to undertake a new review of the “postmarketing safety data on mifepristone for the medical termination of early pregnancy.” In an open letter to the Commissioner, Elliot Institute director David Reardon, has asked Makary to also direct the FDA to require the abortion pill makers to provide the post-abortion follow-up data necessary to develop evidence-based benefit-risk assessments. Get the la…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right1Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium